Full Text (PDF)
Original Article

Comparison of Ramosetron and Ondansetron for Prevention of Postoperative Nausea and Vomiting in Patients on Preoperative Steroids Undergoing Supratentorial Craniotomy: A Prospective, Double-Blind, Randomized Controlled Study

Obaid Ahmad Siddiqui , Hassan Rashid1 , Obaid Ahmad Siddiqui2 , Shahna Ali3 , Zikrullah Zikrullah4 , Manazir Athar5

Author Information

Licence:




International Journal of Neurology and Neurosurgery 11(4):p 269-276, October-December 2019. | DOI: DOI: http://dx.doi.org/10.21088/ijnns.0975.0223.11419.1

How Cite This Article:

Hassan Rashid, Obaid Ahmad Siddiqui, Shahna Ali, et al. Comparison of Ramosetron and Ondansetron for Prevention of Postoperative Nausea and Vomiting in Patients on Preoperative Steroids Undergoing Supratentorial Craniotomy: A Prospective, Double-Blind, Randomized Controlled Study. Int J Neurol Neurosurg. 2019;11(4):269–276.


Timeline

Received : N/A         Accepted : N/A          Published : N/A

Abstract

Background: This study was designed to compare the efficacy of prophylactic ramosetron with ondansetron in preventing PONV after elective supratentorial craniotomy in adult patients on preoperative steroids. Methods: A total of 145 American Society of Anesthesiologists (ASA) I–II patients aged 30–50 years on preoperative steroids scheduled to undergo elective supratentorial craniotomy under general anesthesia were enrolled in the study. A standard anesthesia regimen was followed in all patients. Patients were randomly allocated into two groups to receive ondansetron (4 mg/2 ml; Group O), or ramosetron (0.3 mg/2 ml; Group R) intravenously (IV) at the time of dural closure. The incidence of PONV, need for rescue antiemetics, rescue analgesics and any adverse events were recorded up to 48 hours postoperatively. Results: During 0–24 hours after surgery, complete response (no PONV) was observed in 30 patients of the ondansetron group and in 34 patients of the ramosetron group (p > 0.05). Complete response i.e., no PONV between 24–48 hours after surgery was observed in 31 patients of the ondansetron group and in 45 patients of the ramosetron group and was statistically significant (p < 0.05). During 0–24 hours, PONV requiring rescue antiemetics were comparable in both the groups, whereas between 24–48 hours PONV requiring rescue antiemetics was higher in ondansetron group (18 patients) as compared to ramosetron group (8 patients) and was statistically significant (p < 0.05). Conclusion: Ramosetron was more efficacious than ondansetron in preventing delayed PONV (24–48 hours) in patients on preoperative steroids following supratentorial craniotomy under general anesthesia. However, both the drugs were comparable in preventing early PONV (0–24 hours). The incidence of side effects was similar in ondansetron and ramosetron.

Keywords: Ondansetron; Postoperative nausea and vomiting (PONV); Ramosetron; Supratentorial craniotomy.


References

No records found.


About this article


Cite this article

Hassan Rashid, Obaid Ahmad Siddiqui, Shahna Ali, et al. Comparison of Ramosetron and Ondansetron for Prevention of Postoperative Nausea and Vomiting in Patients on Preoperative Steroids Undergoing Supratentorial Craniotomy: A Prospective, Double-Blind, Randomized Controlled Study. Int J Neurol Neurosurg. 2019;11(4):269–276.


Licence:




Received Accepted Published
N/A N/A N/A

DOI: DOI: http://dx.doi.org/10.21088/ijnns.0975.0223.11419.1

Keywords


Article Level Metrics

Last Updated

Thursday 30 July 2026, 08:06:20 (IST)


1462

Accesses

3
244
00

Citations


NA
NA
NA

Download citation


Article Keywords


Keyword Highlighting

Highlight selected keywords in the article text.


Timeline


Received N/A
Accepted N/A
Published N/A

licence



Access this article



Share